News

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.
AAPLOG Vice Chair Dr. Susan Bane discusses the potential health risks of abortion drugs like mifepristone on ‘Fox & Friends ...
Attorneys and scholars disagree on whether a recent ruling that the FDA’s heightened mifepristone regulations don’t override ...
Greer Donley, a law professor at the University of Pittsburgh, said the ruling could change how states regulate other FDA-approved medication, including vaccines.
The Fourth Circuit Court of Appeals ruled Tuesday, July 15, 2025, in a 2-1 vote that West Virginia can restrict access to the ...
The US Food and Drug Administration held off a legal challenge from a coalition of blue states over the abortion pill, ...
Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...
Good news for activists after Trump administration disappointments. "For us to once again federalize the issue of abortion without a clear directive from Congress, right on the heels of Dobbs, would ...
Food and Drug Administration Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous. While the FDA has yet to announce when this review ...
Study of insurance data raises questions about safety. The father of the abortion pill has died, but questions over the safety of his creation live on. Étienne-Émile Baulieu, the scientist who ...
The ruling reverses the judge’s own decision from two years ago that allowed Washington state and 17 other states to continue ...
” It is long past time for the FDA to reopen its safety review of abortion drugs — a step that is not only warranted but urgently needed.